Edge Cloud
The engine behind the Rapid Enterprise Platform
Platform · HybridCompany source
Company profile
About RapidAI
RapidAI is a leading clinical AI company that delivers the Rapid Enterprise Platform, an advanced clinical decision support system used by healthcare providers worldwide. The platform combines deep clinical AI with workflow integration and enterprise infrastructure to enhance patient assessment and care across multiple disease states. RapidAI specializes in neurovascular conditions including ischemic stroke, hemorrhagic stroke, and aneurysms, as well as cardiac and vascular conditions such as aortic disease and pulmonary embolism. The company's solutions go beyond simple anomaly detection to provide comprehensive capabilities including triage, localization, quantification, characterization, visualization, and longitudinal tracking. With 30 FDA-cleared modules, RapidAI processes over 20,000 scans daily across 2,500+ hospitals in more than 100 countries. The platform features the Rapid mobile app for real-time collaboration and alerts, Navigator Pro for imaging prioritization in radiology, and Rapid Insights for custom performance analytics. RapidAI's technology is backed by extensive clinical validation with 750+ publications, 25+ clinical trials, and 11 publications in the New England Journal of Medicine. The company serves physicians, care teams, hospital administrators, and IT professionals, providing AI-driven precision that enhances patient outcomes, drives operational efficiency, and strengthens financial viability through optimized service lines.
Company description RapidAI official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at RapidAI?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Aneurysms
- Aortic aneurysms
- Cardiac conditions
- Hemorrhagic stroke
- Intracranial hemorrhage
- Ischemic stroke
- Pulmonary embolism
- Thoracic aortic disease
- Vascular conditions
Who it serves
- Care Teams
- Health Systems
- Hospitals
- Neurovascular Centers
- Physicians
- Radiology Departments
- Vascular Surgery
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: DICOM viewer, EMR integration, Third-party interoperability framework.
Geographic context
Markets100+ countries · Global
Company sourceOfficial website
Company milestones
Platform expansion
Lumina 3D by RapidAI named to TIME's List of the Best Inventions. Frost & Sullivan ranking ahead of 96% in industry. Launch of Rapid Aortic solution for aortic patient management.
Partnerships
Recorded partners
- UChicago
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Lumina 3D
TIME's Best Inventions award-winning 3D visualization technology
Software · Cloud SaaSCompany source
Navigator Pro
Imaging prioritization and AI decision support for Radiology
Software · Cloud SaaSCompany source
Rapid Aneurysm
Surface silent risks—track change and guide smarter intervention
Software · Cloud SaaSCompany source
Rapid Aortic
Find and track more aortic patients with AI-driven advanced imaging
Software · Cloud SaaSCompany source
Rapid Enterprise Platform
Clinical AI platform connecting intelligence, workflow, and teams across the health system
Platform · HybridCompany source
Rapid ICH (Hemorrhagic)
AI-driven bleed assessment for faster treatment decisions
Software · Cloud SaaSCompany source
Rapid Insights
Custom performance analytics platform
Platform · Cloud SaaSCompany source
Rapid Mobile App
Real-time collaboration and alerts for urgent cases
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Optimizing Reperfusion Trials: A Consensus Research Roadmap From the STAIR XIII Conference.Stroke · Feb 1, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
54% increase in ICH patients treated
Hemorrhagic stroke care
95% improvement in Joint Commission ICH Score compliance
Quality metrics
98.1% sensitivity for ICH detection
Hemorrhagic stroke detection
99.7% specificity for ICH detection
Hemorrhagic stroke detection
20,000+ daily scans processed
Platform scale
Multiple hospitals (aggregate)
Intracranial hemorrhage detection and treatment
54% increase in ICH patients treated and 95% improvement in Joint Commission ICH Score compliance
UChicago Medicine
Aortic patient management and surveillance
Testimonial from Paul Anain, MD describing Rapid Aortic as 'game-changer for aortic patient management'
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
David Stoffel
CBO (Chief Business Officer)
Paul Anain
Vascular Surgeon (Clinical Advisor/Partner)
06 · Company updates
Updates from RapidAI
Recent articles published on RapidAI's official website.
Why aortic surveillance fails without automated tracking
Read on RapidAIChest imaging: How aortic pathology hides in plain sight
Read on RapidAIMedical imaging AI and the future of neurosurgery
Read on RapidAIBeyond triage: What a truly unified radiology workspace looks like
Read on RapidAIHow AI is turning imaging into a lifelong surveillance tool
Read on RapidAI07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.